Madrigal Pharmaceuticals
MDGL
MDGL
144 hedge funds and large institutions have $1.01B invested in Madrigal Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 44 increasing their positions, 41 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
8% more funds holding
Funds holding: 133 → 144 (+11)
3.78% more ownership
Funds ownership: 66.14% → 69.92% (+3.8%)
7% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 41
Holders
144
Holding in Top 10
3
Calls
$9.96M
Puts
$8.75M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$7.46M | |
| 3 | +$7.32M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$5.51M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.37M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$4.21M | |
| 3 | -$3.07M | |
| 4 |
Two Sigma Advisers
New York
|
-$2.58M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.4M |